Benzinga  Oct 2  Comment 
Esperion Therapeutics (NASDAQ: ESPR) shares reached a new 52-week high of $27.905 after the company announced positive top-line Phase 2b results for ETC-1002. Sagent Pharmaceuticals (NASDAQ: SGNT) shares touched a new 52-week high of $32.12...
SeekingAlpha  Aug 2  Comment 
Reis, Inc. (NASDAQ:REIS) Q2 2014 Earnings Conference Call July 31, 2014 11:00 AM ET Executives Lloyd Lynford – Chief Executive Officer Mark Cantaluppi – Vice President and Chief Financial Officer Analysts Kara Anderson...
Forbes  Jul 2  Comment 
Rents in San Francisco are expensive, and becoming more so: REIS today put the year-over-year rise there at 6.7 percent.  Middle class folks not in rent stabilized buildings are being priced out of San Francisco.  What are the potential policy...
SeekingAlpha  Apr 23  Comment 
By Undiscovered Stocks: As Reis Inc. (REIS) continues to generate significant operating leverage and begins to reaccelerate growth, the company will become a likely acquisition to a larger strategic company, such as Verisk, MSCI, or McGraw...
Wall Street Journal  Apr 1  Comment 
The U.S. office market is showing signs of picking up steam, with businesses adding space in the first quarter at the fastest pace since 2007, according to a report from real-estate data firm Reis Inc.
StreetInsider.com  Mar 6  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Reis%2C+Inc.+%28REIS%29+Tops+Q4+EPS+Views/9253759.html for the full story.
Yahoo  Jan 7  Comment 
(Reuters) - The U.S. apartment vacancy rate eased to its lowest level in more than a decade, but stagnant income growth moderated rent increases, according to an industry report released on Monday. The national apartment vacancy rate fell 0.1...
Yahoo  Jan 6  Comment 
(Reuters) - Office vacancy rates in the United States remained unchanged for the fourth quarter of 2013 because lackluster job growth and concerns about the economy muted demand for office space, a preliminary report by real estate research firm...



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki